Uncertainty Evaluation for the Content Analysis of α-Ketoglutaric Acid

Uncertainty evaluation is a fundamental requirement of modern analytical quality assurance and is essential for the reliable quantitative determination of α-ketoglutaric acid (AKG) in raw materials, supplements, and bioprocess samples. This article presents a complete, standards-based framework—aligned with ISO/IEC 17025:2017 and the GUM (JCGM 100:2008)—for identifying, quantifying, and reporting the measurement uncertainty associated with HPLC-based AKG content analysis. Laboratory analysts, quality managers, and regulatory specialists will find practical guidance on uncertainty budgeting, calculation, and conformity assessment decisions.

Technical Overview

α-Ketoglutaric acid (2-oxopentanedioic acid, CAS 328-50-7, molecular formula C5H6O5, molecular weight 146.10 g/mol) is a five-carbon dicarboxylic keto acid that occupies a central position in the tricarboxylic acid (TCA) cycle and in nitrogen transamination pathways. Because of its physiological significance and its growing use in dietary supplements, pharmaceutical intermediates, cell culture media, and cosmetic formulations, accurate quantification of AKG content is a critical quality attribute.

In routine practice, AKG content is most commonly determined by high-performance liquid chromatography (HPLC) with ultraviolet detection near 210 nm, refractive index detection, or ion-exclusion chromatography, using an external standard calibration approach. Whatever the technique, no measurement result is complete without a statement of its doubt. Measurement uncertainty is a parameter characterizing the dispersion of values that could reasonably be attributed to the measurand, and its evaluation follows the internationally recognized approach described in the Guide to the Expression of Uncertainty in Measurement (GUM, JCGM 100:2008) and the EURACHEM/CITAC Guide CG4 for analytical chemistry.

ISO/IEC 17025:2017 explicitly requires testing laboratories to evaluate measurement uncertainty for quantitative test methods and to apply documented decision rules when statements of conformity are issued. A rigorous uncertainty evaluation for AKG content analysis therefore serves three purposes: it demonstrates metrological competence, it supports defensible pass/fail decisions against specifications, and it identifies which steps of the procedure dominate the overall uncertainty so that method optimization can be targeted effectively.

Testing Samples

Dietary Supplement and Nutraceutical Raw Materials

Crystalline α-ketoglutaric acid and its salt forms, including calcium α-ketoglutarate (Ca-AKG) and arginine α-ketoglutarate (AAKG), constitute the largest category of samples. These materials are typically assayed on an as-is basis, with parallel determination of water content by Karl Fischer titration and residual solvents by headspace GC, both of which may feed into the uncertainty of the reported as-is or dry-basis purity.

Pharmaceutical Intermediates

AKG used as a synthetic intermediate or in parenteral nutrition formulations requires high-purity assay with full uncertainty traceability to support regulatory submissions and batch release documentation.

Fermentation Broths and Bioprocess Streams

In microbial fermentation processes, AKG accumulates as an extracellular metabolite. Matrix-rich fermentation samples require pretreatment steps—centrifugation, dilution, and filtration—each of which introduces additional uncertainty components that must be captured in the budget.

Functional Foods and Cosmetic Formulations

Finished products such as beverages, powders, and creams contain AKG at low concentrations within complex matrices, where extraction recovery and matrix effects often become significant uncertainty contributors.

Testing Items

The core testing item is the AKG mass fraction, expressed as a percentage (g per 100 g), reported on either an as-is or dry-basis reference. The uncertainty evaluation described here covers the complete measurement chain associated with this result, including:

• Mass fraction of α-ketoglutaric acid in the test sample (primary measurand)
• Concentration of AKG calibration solutions and their traceability
• Method precision across independent sample preparations
• Influence of water content and impurity profile on the reported basis

Testing Methods

Chromatographic Determination Procedure

A representative sample of approximately 250 mg is accurately weighed into a volumetric flask, dissolved in mobile phase or purified water, sonicated, diluted to volume, and further diluted as required to bring the final concentration within the validated linear range. The solution is filtered through a 0.45 µm membrane before injection. Because AKG is prone to hydration and degradation in dilute aqueous solution at elevated temperature, solutions should be prepared fresh and analyzed promptly, preferably within a few hours at controlled room temperature.

Typical HPLC conditions include a C18 or ion-exclusion column operated isocratically with a dilute acid mobile phase (for example, 0.01 mol/L sulfuric acid or a phosphate buffer at pH 2.5), UV detection at 210 nm, column temperature of 25–30 °C, and an injection volume of 10–20 µL. Quantification is performed by external standard calibration using a certified reference material or a working standard of certified purity, with five calibration levels prepared in duplicate and bracketed injections of quality control samples.

Mathematical Model of the Measurement

The mass fraction of AKG is calculated from the measured concentration of the test solution according to the model:

w = (c × V × F) / m × 100%

where c is the mass concentration of AKG in the test solution obtained from the calibration curve (mg/mL), V is the final volumetric dilution volume (mL), F is the product of all intermediate dilution factors, and m is the sample mass (mg). Every input quantity in this model is a potential uncertainty source, and the combined uncertainty is propagated from the individual components.

Identification of Uncertainty Sources

A cause-and-effect analysis of the procedure identifies the following principal contributors:

• Sample mass: balance readability, repeatability, and calibration for both tare and gross weighings
• Volumetric operations: calibration tolerances of volumetric flasks, pipettes, and dilutors used in sample and standard preparation
• Reference standard purity: uncertainty of the certified purity value stated on the certificate of analysis
• Calibration curve: residual standard deviation of the least-squares fit, number of calibration levels, and number of replicate injections of the unknown
• Method repeatability: combined effect of sample heterogeneity, extraction, and injection variability across independent preparations
• Environmental conditions: temperature deviation from the volumetric calibration temperature of 20 °C affecting solution volumes
• Instrumental factors: injection volume precision, detector drift, and baseline-dependent peak integration

Evaluation of Individual Uncertainty Components

Type A evaluation is applied to the repeatability component: six independent sample preparations yield a relative standard deviation of 2.0%, and the standard uncertainty of the mean is 2.0%/√6 = 0.82%. Type B evaluation applies to the remaining components, assuming rectangular distributions for instrument and glassware tolerances, so that u = a/√3 for a half-width a. The reference standard certificate states P = 99.4% with expanded uncertainty 0.6% (k = 2), giving a relative standard uncertainty of 0.30%. The uncertainty of the concentration assigned to the unknown from the calibration curve is derived from the standard expression u(c0) = (s/b) × √(1/m + 1/n + (c0 − c̄)²/Σ(cj − c̄)²), where s is the residual standard deviation, b the slope, m the number of replicate injections of the unknown, n the total number of calibration points, and c̄ the mean calibration concentration, yielding a relative contribution of 0.58%. The mass term contributes 0.041%, the volumetric dilution chain 0.17%, and the temperature effect 0.05%.

Combined and Expanded Uncertainty

Because the model is multiplicative, relative standard uncertainties are combined in quadrature:

u_c,rel = √(0.0082² + 0.0058² + 0.0030² + 0.00041² + 0.0017² + 0.0005²) = 1.07%

For a representative mean result of 99.2% (as-is), the combined standard uncertainty is u_c = 99.2% × 0.0107 = 1.06%. The expanded uncertainty is obtained by multiplying with a coverage factor k = 2, corresponding to a coverage probability of approximately 95% for a normal distribution: U = 2 × 1.06% = 2.1%.

Reporting of Results

The final result is reported as: AKG content = (99.2 ± 2.1)% (k = 2, approximately 95% confidence level). The uncertainty statement should reference the evaluation basis (GUM, JCGM 100:2008), the dominant uncertainty components, and, when statements of conformity are required, the decision rule applied—for example, simple acceptance or guard-banded acceptance in which the acceptance limit is tightened by the expanded uncertainty.

Applications

• Batch release testing of AKG and AKG salt raw materials against pharmacopoeial or in-house specifications, with defensible conformity statements under ISO/IEC 17025:2017 clause 7.8.6
• Stability studies, where uncertainty bounds determine whether statistically significant degradation has occurred across storage time points
• Method validation and transfer, using the uncertainty budget to compare precision between laboratories and to set realistic system suitability criteria
• Proficiency testing and interlaboratory comparisons, where the reported expanded uncertainty is used to calculate En numbers or zeta scores
• Regulatory documentation, including dietary ingredient notifications and drug master files, demonstrating metrological traceability of assay results
• Bioprocess development, in which uncertainty analysis distinguishes true process trends from analytical noise in fermentation time-course data

FAQ

What is the difference between measurement error and measurement uncertainty?

Error is a single signed deviation of an individual result from a true value, while uncertainty is a non-negative parameter characterizing the dispersion of all values that could reasonably be attributed to the measurand. Uncertainty is evaluated statistically (Type A) from repeated observations or by other means (Type B) from calibration certificates, tolerances, and prior data; it cannot be corrected away but is instead quantified and reported.

Why is a coverage factor of k = 2 used?

A coverage factor of 2 provides an expanded uncertainty corresponding to approximately 95% coverage probability under the assumption of normality and adequate degrees of freedom. For components with low degrees of freedom, the effective degrees of freedom should be estimated using the Welch–Satterthwaite formula and k taken from the t-distribution accordingly.

Which component usually dominates the uncertainty budget for AKG analysis?

In most HPLC-based assays, method repeatability and calibration curve fitting dominate, together accounting for the majority of the variance, while weighing and dilution contribute little. This means that improving injection precision, increasing the number of sample preparations, and optimizing calibration design will reduce the expanded uncertainty far more effectively than upgrading glassware.

How does water content affect the reported uncertainty?

If results are reported on a dry basis, the uncertainty of the Karl Fischer water determination must be propagated into the final result as an additional component. On an as-is basis, water content variability is embedded within the repeatability term but should be assessed separately when samples are hygroscopic.

How often should the uncertainty evaluation be reviewed?

The budget should be revalidated whenever the method, instrument, reference standard lot, or sample matrix changes materially, and reviewed at least annually as part of the quality system. Significant deviations observed in control charts or proficiency testing results also trigger reassessment.

Can the expanded uncertainty be used for pass/fail decisions?

Yes. Under ISO/IEC 17025:2017, a documented decision rule must be agreed with the client. In guard-banded acceptance, a result within ±U of a specification limit is reported as conditionally conforming or non-conforming, whereas simple acceptance accepts results within the limit. The chosen rule must be stated explicitly on the test report.